Genesco (NYSE:GCO) Stock Dropped to Hold by Wall Street Zen

Wall Street Zen cut shares of Genesco (NYSE:GCO – Free Report) from a buy rating to a hold rating in a research report report published on Saturday,Wall Street Zen reports.

Several other analysts have also issued reports on the company. Truist Financial reduced their target price on Genesco from $40.00 to $38.00 and set a “hold” rating on the stock in a report on Friday, September 4th. Zacks Research cut shares of Genesco from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 2nd. Finally, Weiss Ratings upgraded shares of Genesco from a “sell (d+)” rating to a “hold (c)” rating in a research report on Tuesday, September 22nd. One analyst has rated the stock with a Strong Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $36.00.

View Our Latest Research Report on Genesco

Genesco Trading Down 2.9%

NYSE:GCO opened at $32.75 on Friday. The stock has a market capitalization of $354.34 million, a PE ratio of 8.53 and a beta of 1.82. Genesco has a fifty-two week low of $21.92 and a fifty-two week high of $43.60. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.58 and a quick ratio of 0.32. The business’s 50-day simple moving average is $35.76 and its 200-day simple moving average is $33.81.

Genesco (NYSE:GCO – Get Free Report) last released its earnings results on Thursday, September 3rd. The company reported ($0.83) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.37) by $0.54. Genesco had a return on equity of 3.14% and a net margin of 1.71%. The firm had revenue of $529.86 million during the quarter, compared to analysts’ expectations of $527.26 million. During the same quarter in the prior year, the company earned ($1.79) EPS. Genesco has set its FY 2027 guidance at 2.000-2.400 EPS. Sell-side analysts expect that Genesco will post 2.35 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Genesco

A number of institutional investors and hedge funds have recently made changes to their positions in GCO. American Century Companies Inc. grew its stake in shares of Genesco by 76.0% in the 3rd quarter. American Century Companies Inc. now owns 344,825 shares of the company’s stock valued at $11,772,000 after buying an additional 148,856 shares during the period. DGS Capital Management LLC bought a new stake in Genesco in the 3rd quarter valued at about $205,000. Allworth Financial LP increased its position in Genesco by 131.5% in the 3rd quarter. Allworth Financial LP now owns 838 shares of the company’s stock valued at $29,000 after buying an additional 476 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in Genesco by 54.1% during the 3rd quarter. Goldman Sachs Group Inc. now owns 121,096 shares of the company’s stock worth $4,134,000 after buying an additional 42,538 shares during the period. Finally, State of Tennessee Department of Treasury acquired a new position in Genesco during the 3rd quarter worth approximately $107,000. Institutional investors own 94.51% of the company’s stock.

About Genesco

(Get Free Report)

Genesco Inc. is a Nashville-based footwear retailer and brand operator. Its retail businesses include Journeys and Journeys Kidz in the United States, Schuh in the United Kingdom and Ireland, Little Burgundy in Canada, and Johnston & Murphy, which sells footwear, apparel and accessories. The company also develops, sources and markets footwear through its Genesco Brands Group, serving retail partners as well as its own businesses. Its product range includes casual, athletic-inspired and dress footwear, along with related apparel and accessories.

See Also

Analyst Recommendations for Genesco (NYSE:GCO)

Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.